Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
Glucagon is used for the treatment of hypoglycemia, and glucagon receptor antagonists are under development for the treatment of type 2 diabetes. Moreover, glucagon-like peptide (GLP)-1 and GLP-2 receptor agonists appear to be promising therapies for the treatment of type 2 diabetes and intestinal disorders, respectively. This review discusses the physiological, pharmacological, and therapeutic actions of the proglucagon-derived peptides, with an emphasis on clinical relevance of the peptides for the treatment of human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DeFronzo, R. A., Ratner, R. E., Han, J., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1092 · Cited by 1,559
Buse, J. B., Henry, R. R., Han, J., Kim, D. D., Fineman, M. S., Baron, A. D., & for the Exenatide-113 Clinical Study Group (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2628 · Cited by 1,346
Kendall, D. M., Riddle, M. C., Rosenstock, J., Zhuang, D., Kim, D. D., Fineman, M. S., & Baron, A. D. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1083 · Cited by 1,177
Cryer, P. E., Davis, S. N., & Shamoon, H. (2003) · Diabetes Care · doi:10.2337/diacare.26.6.1902 · Cited by 1,160
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Eng, J., Kleinman, W. A., Singh, L., Singh, G., & Raufman, J. P. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42531-8 · Cited by 1,000
Glucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
Drucker, D. J., Philippe, J., Mojsov, S., Chick, W. L., & Habener, J. F. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3434 · Cited by 903
Self-citationGutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Glucagon-like peptide-1 receptor is involved in learning and neuroprotection
During, M. J., Cao, L., Zuzga, D. S., Francis, J. S., Fitzsimons, H. L., Jiao, X., Bland, R. J., Klugmann, M., Banks, W. A., Drucker, D. J., et al. (2003) · Nature Medicine · doi:10.1038/nm919 · Cited by 851
Self-citation
Research works printed but not linked: 101
- 10.1016/S0014-2999(00)00600-2 · DOI · Paper page
- 10.1053/jpsu.2000.6861 · DOI
- 10.1097/00006676-200005000-00003 · DOI · Paper page
- 10.2337/diabetes.53.9.2492 · DOI · Paper page
- 10.1016/0167-0115(88)90099-7 · DOI
- 10.1007/s001250051445 · DOI · Paper page
- 10.1152/ajpendo.1994.266.3.E459 · DOI · Paper page
- 10.1136/gut.47.1.112 · DOI · Paper page
- 10.2337/diabetes.54.1.146 · DOI · Paper page
- 10.1152/ajpendo.1999.277.5.E937 · DOI · Paper page
- 10.1007/BF00400461 · DOI
- 10.1210/endo.138.11.5482 · doi:10.1210/endo.138.11.5482 · Paper page
- 10.1152/ajpendo.1997.272.6.E1050 · DOI · Paper page
- 10.1210/en.2004-1119 · DOI
- 10.1152/ajpgi.2000.279.6.G1249 · DOI · Paper page
- 10.2337/diabetes.52.1.124 · DOI · Paper page
- 10.2337/diabetes.50.10.2237 · DOI · Paper page
- 10.1152/ajpgi.00231.2002 · DOI · Paper page
- 10.1210/endo.134.5.8156917 · doi:10.1210/endo.134.5.8156917 · Paper page
- 10.1152/ajpgi.1996.271.3.G477 · DOI · Paper page
- 10.1210/jc.2003-030421 · DOI · Paper page
- 10.1053/gast.1997.v112.pm9178688 · DOI
- 10.1210/endo.142.10.8430 · DOI · Paper page
- 10.2337/diabetes.52.2.365 · DOI · Paper page
- 10.2337/diab.44.9.1126 · DOI · Paper page
- DhanvantariS, Seidah NG, and Brubaker PL. Role of prohormone convertases in the tissue-specific processing of proglucagon.Mol Endocrinol10: 342–355, 1996. · doi:10.1210/mend.10.4.8721980 · Paper page
- 10.1210/me.2002-0306 · DOI · Paper page
- 10.1073/pnas.93.15.7911 · DOI · Paper page
- 10.1038/nbt0797-673 · DOI · Paper page
- 10.1152/ajpgi.1999.276.1.G79 · DOI · Paper page
- 10.1055/s-2004-826159 · DOI · Paper page
- 10.1016/S0303-7207(98)00096-3 · DOI · Paper page
- 10.1210/en.2004-1389 · DOI
- 10.1210/endo.130.1.1309325 · doi:10.1210/endo.130.1.1309325 · Paper page
- FurutaM, Yano H, Zhou A, Rouille Y, Holst JJ, Carroll R, Ravazolla M, Orci L, Furuta H, and Steiner DF. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.Proc Natl Acad Sci USA94: 6646–6651, 1999. · DOI · Paper page
- 10.1073/pnas.0237106100 · DOI · Paper page
- 10.1074/jbc.M209165200 · DOI · Paper page
- 10.1210/en.2003-0007 · DOI · Paper page
- 10.1016/S0016-5085(03)00667-X · DOI · Paper page
- 10.1080/003655202317316006 · DOI
- 10.1152/ajpendo.00197.2004 · DOI · Paper page
- 10.1016/0196-9781(95)00078-X · DOI
- 10.2337/diacare.27.8.1915 · DOI · Paper page
- HartmannB, Harr MB, Jeppesen PB, Wojdemann M, Deacon CF, Mortensen PB, and Holst JJ. In vivo and in vitro degradation of glucagon-like peptide-2 in humans.J Clin Endocrinol Metab85: 2884–2888, 2000. · DOI · Paper page
- 10.1016/0014-5793(85)80879-6 · DOI
- 10.1210/endo-115-1-102 · DOI
- 10.1126/science.8384375 · DOI · Paper page
- 10.1053/gast.2001.22555 · DOI · Paper page
- 10.1126/science.6278587 · DOI · Paper page
- 10.1111/j.1469-7793.2001.0375c.xd · DOI · Paper page
- 10.1074/jbc.M108378200 · DOI · Paper page
- 10.2337/diabetes.52.3.751 · DOI · Paper page
- 10.1523/JNEUROSCI.22-23-10470.2002 · DOI · Paper page
- 10.1038/297156a0 · DOI
- 10.1210/me.2004-0196 · DOI
- 10.1210/jc.2002-021545 · DOI · Paper page
- 10.2337/diabetes.51.3.691 · DOI · Paper page
- 10.2337/diabetes.53.2.410 · DOI · Paper page
- 10.1007/s004280000374 · DOI
- 10.2337/diacare.27.6.1335 · DOI · Paper page
- 10.1073/pnas.120069197 · DOI · Paper page
- 10.1124/pr.55.1.6 · DOI · Paper page
- 10.1016/0167-0115(93)90435-B · DOI · Paper page
- 10.1073/pnas.96.4.1569 · DOI · Paper page
- 10.1007/BF02934484 · DOI
- 10.1006/bbrc.2001.4999 · DOI
- 10.1016/0026-0495(95)90288-0 · DOI
- 10.1016/j.regpep.2004.07.009 · DOI · Paper page
- 10.1210/endo-119-4-1467 · DOI · Paper page
- 10.1210/endo-123-4-2009 · DOI · Paper page
- 10.2337/diab.47.8.1253 · DOI · Paper page
- 10.1007/s001250100006 · DOI · Paper page
- 10.1053/jpsu.2001.22284 · doi:10.1053/jpsu.2001.22284
- 10.1016/S0022-3468(00)90040-X · DOI
- 10.2337/diabetes.53.12.3267 · DOI · Paper page
- 10.1210/endo.140.4.6643 · doi:10.1210/endo.140.4.6643 · Paper page
- 10.1074/jbc.270.17.10136 · DOI · Paper page
- 10.1073/pnas.91.8.3242 · DOI · Paper page
- 10.1139/y90-239 · DOI · Paper page
- 10.1007/BF01538078 · DOI
- 10.1111/j.1365-2362.1988.tb01046.x · DOI · Paper page
- 10.1152/ajpgi.1998.275.5.G911 · DOI · Paper page
- 10.1080/003655201750422648 · DOI
- 10.1053/j.gastro.2005.02.033 · DOI
- 10.1210/endo.137.11.8895391 · DOI · Paper page
- 10.2337/diabetes.49.7.1156 · DOI · Paper page
- 10.1172/JCI20911 · doi:10.1172/jci20911 · Paper page
- 10.1016/0303-7207(94)90162-7 · DOI
- 10.1006/jsre.2000.5917 · DOI
- 10.1152/ajpendo.2000.278.1.E134 · DOI · Paper page
- 10.2337/diab.42.11.1678 · DOI · Paper page
- 10.1016/S0167-0115(01)00316-0 · DOI
- 10.1007/s00125-005-1692-8 · DOI
- 10.1080/00365529850171486 · DOI · Paper page
- 10.1016/S0016-5085(99)70555-X · DOI · Paper page
- YewKH, Hembree M, Prasadan K, Preuett B, McFall C, Benjes C, Crowley A, Sharp S, Tulachan S, Mehta S, Tei E, and Gittes G. Crosstalk between BMP and TGF-beta signaling is essential for exendin-4 induced insulin-positive differentiation of AR42J cells.J Biol Chem. In press.
- 10.1074/jbc.M005510200 · DOI
- 10.1074/jbc.M201358200 · DOI
- 10.1053/gast.2000.16489 · DOI · Paper page
- 10.1074/jbc.274.43.30459 · DOI · Paper page
- 10.2337/diabetes.48.12.2358 · DOI · Paper page
Cited by
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Roopchand, D. E., Carmody, R. N., Kuhn, P., Moskal, K., Rojas-Silva, P., Turnbaugh, P. J., & Raskin, I. (2015) · Diabetes · doi:10.2337/db14-1916 · Cited by 678
Everard, A., & Cani, P. D. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9288-6 · Cited by 261
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Amato, A., Cinci, L., Rotondo, A., Serio, R., Faussone-pellegrini, M. S., Vannucchi, M. G., & Mulè, F. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01476.x · Cited by 124
Metadata
- Authors
- Sinclair, E. M., & Drucker, D. J.
- Venue
- Physiology
- Publisher
- American Physiological Society
- Published
- 2005-10
- Volume
- 20
- Issue
- 5
- Pages
- 357-365
- ISSN
- 0886-1714 (ISSN-L)
- 1548-9213
- 1548-9221
- OpenAlex
- W2088954563
- Cited by
- 87
- References
- 28
- FWCI
- 4.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential. https://app.cochat.ai/papers/10.1152/physiol.00030.2005
- The paper
- Sinclair, E. M., & Drucker, D. J. (2005). Proglucagon-Derived Peptides: Mechanisms of Action and Therapeutic Potential. Physiology. https://doi.org/10.1152/physiol.00030.2005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.